Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Paul Matteis's Stock Ratings
Stifel Analyst
Paul Matteis is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/25/2025
Overall Average Return
-13.8%
Smart Score
Overall Average Return Percentile
19th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/31/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | 42.71% | Paul Matteis41% | $300 → $345 | Maintains | Buy | Get Alert |
| 03/07/2025 | NMRA | Buy Now | Neumora Therapeutics | $0.75 | 166.7% | Paul Matteis41% | $6 → $2 | Downgrade | Buy → Hold | Get Alert |
| 03/05/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $62.97 | 23.87% | Paul Matteis41% | → $78 | Reinstates | → Buy | Get Alert |
| 03/04/2025 | SION | Buy Now | Sionna Therapeutics | $12.60 | 153.97% | Paul Matteis41% | → $32 | Initiates | → Buy | Get Alert |
| 02/27/2025 | CMPS | Buy Now | Compass Pathways | $3.99 | 175.7% | Paul Matteis41% | → $11 | Initiates | → Buy | Get Alert |
| 02/27/2025 | GHRS | Buy Now | GH Research | $9.23 | 246.7% | Paul Matteis41% | $18 → $32 | Maintains | Buy | Get Alert |
| 12/16/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | 0.85% | Paul Matteis41% | $490 → $494 | Maintains | Hold | Get Alert |
| 12/16/2024 | QURE | Buy Now | uniQure | $14.94 | 114.19% | Paul Matteis41% | $12 → $32 | Maintains | Buy | Get Alert |
| 12/16/2024 | SAGE | Buy Now | Sage Therapeutics | $7.79 | -22.98% | Paul Matteis41% | $10 → $6 | Maintains | Hold | Get Alert |
| 12/16/2024 | ALEC | Buy Now | Alector | $1.28 | 213.31% | Paul Matteis41% | → $4 | Downgrade | Buy → Hold | Get Alert |
| 11/13/2024 | ANRO | Buy Now | Alto Neuroscience | $2.28 | 338.6% | Paul Matteis41% | $32 → $10 | Maintains | Buy | Get Alert |
| 11/12/2024 | NGNE | Buy Now | Neurogene | $15.37 | 290.37% | Paul Matteis41% | $44 → $60 | Maintains | Buy | Get Alert |
| 11/05/2024 | ALKS | Buy Now | Alkermes | $27.67 | 30.1% | Paul Matteis41% | $25 → $36 | Upgrade | Hold → Buy | Get Alert |
| 09/17/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.74 | 38.67% | Paul Matteis41% | $115 → $87 | Maintains | Buy | Get Alert |
| 08/21/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.74 | 83.3% | Paul Matteis41% | $112 → $115 | Maintains | Buy | Get Alert |
| 08/16/2024 | DYN | Buy Now | Dyne Therapeutics | $11.47 | 475.35% | Paul Matteis41% | $41 → $66 | Maintains | Buy | Get Alert |
| 08/06/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.74 | 78.51% | Paul Matteis41% | $108 → $112 | Maintains | Buy | Get Alert |
| 07/02/2024 | RAPP | Buy Now | Rapport Therapeutics | $11.10 | 215.32% | Paul Matteis41% | → $35 | Initiates | → Buy | Get Alert |
| 06/27/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $29.57 | 79.24% | Paul Matteis41% | $50 → $53 | Maintains | Hold | Get Alert |
| 06/27/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | 22.03% | Paul Matteis41% | $215 → $295 | Maintains | Buy | Get Alert |
| 05/09/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.83 | 41.6% | Paul Matteis41% | $26 → $21 | Maintains | Hold | Get Alert |
| 04/30/2024 | CTNM | Buy Now | Contineum Therapeutics | $4.52 | 541.59% | Paul Matteis41% | → $29 | Initiates | → Buy | Get Alert |
| 03/25/2024 | ANRO | Buy Now | Alto Neuroscience | $2.28 | 1303.51% | Paul Matteis41% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | DYN | Buy Now | Dyne Therapeutics | $11.47 | 257.41% | Paul Matteis41% | $35 → $41 | Maintains | Buy | Get Alert |
| 02/27/2024 | ANRO | Buy Now | Alto Neuroscience | $2.28 | 1303.51% | Paul Matteis41% | → $32 | Initiates | → Buy | Get Alert |
| 01/05/2024 | NGNE | Buy Now | Neurogene | $15.37 | 101.69% | Paul Matteis41% | → $31 | Initiates | → Buy | Get Alert |
| 12/21/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.74 | 60.98% | Paul Matteis41% | → $101 | Reiterates | Buy → Buy | Get Alert |
| 12/18/2023 | SAGE | Buy Now | Sage Therapeutics | $7.79 | 156.74% | Paul Matteis41% | $22 → $20 | Maintains | Hold | Get Alert |
| 12/18/2023 | NBIX | Buy Now | Neurocrine Biosciences | $105.76 | 36.16% | Paul Matteis41% | $141 → $144 | Maintains | Buy | Get Alert |
| 12/18/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $29.57 | 69.09% | Paul Matteis41% | $45 → $50 | Maintains | Hold | Get Alert |
| 12/18/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.83 | 82.06% | Paul Matteis41% | $25 → $27 | Maintains | Hold | Get Alert |
| 12/14/2023 | BIIB | Buy Now | Biogen | $118.41 | 142.38% | Paul Matteis41% | $315 → $287 | Maintains | Buy | Get Alert |
| 12/14/2023 | ALEC | Buy Now | Alector | $1.28 | 1074.9% | Paul Matteis41% | $8 → $15 | Upgrade | Hold → Buy | Get Alert |
| 11/28/2023 | LXEO | Buy Now | Lexeo Therapeutics | $3.49 | 473.07% | Paul Matteis41% | → $20 | Initiates | → Buy | Get Alert |
| 11/22/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -23.85% | Paul Matteis41% | → $373 | Reiterates | Hold → Hold | Get Alert |
| 11/14/2023 | VTGN | Buy Now | Vistagen Therapeutics | $2.18 | 450.46% | Paul Matteis41% | → $12 | Initiates | → Buy | Get Alert |
| 11/07/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -23.85% | Paul Matteis41% | $340 → $373 | Maintains | Hold | Get Alert |
| 10/10/2023 | NMRA | Buy Now | Neumora Therapeutics | $0.75 | 3367.13% | Paul Matteis41% | → $26 | Initiates | → Buy | Get Alert |
| 09/14/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -0.72% | Paul Matteis41% | → $240 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2023 | ALEC | Buy Now | Alector | $1.28 | 526.62% | Paul Matteis41% | $10 → $8 | Maintains | Hold | Get Alert |
| 08/07/2023 | SAGE | Buy Now | Sage Therapeutics | $7.79 | 182.41% | Paul Matteis41% | $60 → $22 | Downgrade | Buy → Hold | Get Alert |
| 08/01/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.74 | 72.14% | Paul Matteis41% | $118 → $108 | Maintains | Buy | Get Alert |
| 07/25/2023 | BIIB | Buy Now | Biogen | $118.41 | 170.25% | Paul Matteis41% | $324 → $320 | Maintains | Buy | Get Alert |
| 06/14/2023 | PEPG | Buy Now | PepGen | $1.68 | 1328.57% | Paul Matteis41% | → $24 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | ALKS | Buy Now | Alkermes | $27.67 | 19.26% | Paul Matteis41% | $31 → $33 | Maintains | Hold | Get Alert |
| 06/06/2023 | NBIX | Buy Now | Neurocrine Biosciences | $105.76 | 18.19% | Paul Matteis41% | $145 → $125 | Maintains | Buy | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -30.59% | Paul Matteis41% | $300 → $340 | Maintains | Hold | Get Alert |
| 02/28/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.74 | 88.08% | Paul Matteis41% | $114 → $118 | Maintains | Buy | Get Alert |
| 02/09/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -38.76% | Paul Matteis41% | $289 → $300 | Maintains | Hold | Get Alert |
| 10/30/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -41% | Paul Matteis41% | → $289 | Maintains | Hold | Get Alert |
| 10/13/2022 | BIIB | Buy Now | Biogen | $118.41 | 152.51% | Paul Matteis41% | → $299 | Upgrade | Hold → Buy | Get Alert |
| 09/13/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Paul Matteis41% | $260 → $295 | Maintains | Buy | Get Alert |
| 09/12/2022 | BIIB | Buy Now | Biogen | $118.41 | 88.33% | Paul Matteis41% | $230 → $223 | Maintains | Hold | Get Alert |
| 08/10/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -46.31% | Paul Matteis41% | → $263 | Maintains | Hold | Get Alert |
| 08/09/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Paul Matteis41% | $50 → $54 | Maintains | Buy | Get Alert |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Paul Matteis41% | $185 → $260 | Maintains | Buy | Get Alert |
| 06/23/2022 | ATHA | Buy Now | Athira Pharma | $0.30 | 1544.2% | Paul Matteis41% | $36 → $5 | Downgrade | Buy → Hold | Get Alert |
| 06/08/2022 | KALV | Buy Now | KalVista Pharma | $12.88 | 148.45% | Paul Matteis41% | $54 → $32 | Maintains | Buy | Get Alert |
| 05/31/2022 | PEPG | Buy Now | PepGen | $1.68 | 1328.57% | Paul Matteis41% | → $24 | Initiates | → Buy | Get Alert |
| 05/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -51.01% | Paul Matteis41% | $222 → $240 | Maintains | Hold | Get Alert |
| 03/08/2022 | ALEC | Buy Now | Alector | $1.28 | 1309.88% | Paul Matteis41% | $32 → $18 | Downgrade | Buy → Hold | Get Alert |
| 03/08/2022 | BIIB | Buy Now | Biogen | $118.41 | 88.33% | Paul Matteis41% | $304 → $223 | Downgrade | Buy → Hold | Get Alert |
| 02/01/2022 | VIGL | Buy Now | Vigil Neuroscience | $1.80 | 1233.33% | Paul Matteis41% | → $24 | Initiates | → Buy | Get Alert |
| 01/27/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -54.68% | Paul Matteis41% | $213 → $222 | Maintains | Hold | Get Alert |
| 10/15/2021 | BIIB | Buy Now | Biogen | $118.41 | 190.52% | Paul Matteis41% | $430 → $344 | Maintains | Buy | Get Alert |
| 10/04/2021 | SAGE | Buy Now | Sage Therapeutics | $7.79 | 862.77% | Paul Matteis41% | $95 → $75 | Maintains | Buy | Get Alert |
| 09/09/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -56.52% | Paul Matteis41% | $244 → $213 | Downgrade | Buy → Hold | Get Alert |
| 09/09/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.74 | 53.01% | Paul Matteis41% | $86 → $96 | Upgrade | Hold → Buy | Get Alert |
| 09/07/2021 | ELYM | Buy Now | Eliem Therapeutics | — | — | Paul Matteis41% | → $35 | Initiates | → Buy | Get Alert |
| 07/26/2021 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.11 | 2339.02% | Paul Matteis41% | → $27 | Initiates | → Buy | Get Alert |
| 07/20/2021 | GHRS | Buy Now | GH Research | $9.23 | 181.69% | Paul Matteis41% | → $26 | Initiates | → Buy | Get Alert |
| 06/16/2021 | SAGE | Buy Now | Sage Therapeutics | $7.79 | 1119.51% | Paul Matteis41% | $121 → $95 | Maintains | Buy | Get Alert |
| 06/11/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -50.19% | Paul Matteis41% | $277 → $244 | Maintains | Buy | Get Alert |
| 03/09/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.83 | 82.06% | Paul Matteis41% | $68 → $27 | Downgrade | Buy → Hold | Get Alert |
| 12/17/2020 | PRVL | Buy Now | Prevail Therapeutics | — | — | Paul Matteis41% | $23 → $23 | Downgrade | Buy → Hold | Get Alert |
| 11/09/2020 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Paul Matteis41% | → $17 | Initiates | → Buy | Get Alert |
| 10/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -43.45% | Paul Matteis41% | $309 → $277 | Maintains | Buy | Get Alert |
| 10/13/2020 | ATHA | Buy Now | Athira Pharma | $0.30 | 11738.21% | Paul Matteis41% | → $36 | Initiates | → Buy | Get Alert |
| 10/12/2020 | DYN | Buy Now | Dyne Therapeutics | $11.47 | 152.8% | Paul Matteis41% | → $29 | Initiates | → Buy | Get Alert |
| 08/19/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $62.74 | 59.39% | Paul Matteis41% | $127 → $100 | Downgrade | Buy → Hold | Get Alert |
| 07/31/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -36.92% | Paul Matteis41% | $285 → $309 | Maintains | Buy | Get Alert |
| 07/16/2020 | PRVL | Buy Now | Prevail Therapeutics | — | — | Paul Matteis41% | → $23 | Initiates | → Buy | Get Alert |
| 07/15/2020 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Paul Matteis41% | $150 → $140 | Downgrade | Buy → Hold | Get Alert |
| 07/07/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.83 | 378.76% | Paul Matteis41% | $41 → $71 | Upgrade | Hold → Buy | Get Alert |
| 06/03/2020 | KRTX | Buy Now | Karuna Therapeutics | — | — | Paul Matteis41% | $126 → $135 | Maintains | Buy | Get Alert |
| 04/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -41.82% | Paul Matteis41% | $275 → $285 | Maintains | Buy | Get Alert |
| 03/12/2020 | AVDL | Buy Now | Avadel Pharmaceuticals | $8.60 | 62.79% | Paul Matteis41% | → $14 | Initiates | → Buy | Get Alert |
| 01/31/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -43.86% | Paul Matteis41% | $243 → $275 | Maintains | Buy | Get Alert |
| 12/19/2019 | KRTX | Buy Now | Karuna Therapeutics | — | — | Paul Matteis41% | → $126 | Initiates | → Buy | Get Alert |
| 10/31/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -53.25% | Paul Matteis41% | $211 → $229 | Maintains | Buy | Get Alert |
| 09/03/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.83 | 88.81% | Paul Matteis41% | $24 → $28 | Maintains | Hold | Get Alert |
| 08/01/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -56.93% | Paul Matteis41% | $205 → $211 | Maintains | Buy | Get Alert |
| 04/15/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -52.02% | Paul Matteis41% | $110 → $116 | Maintains | Buy | Get Alert |
| 11/28/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -73.94% | Paul Matteis41% | → $63 | Initiates | → Market Perform | Get Alert |
| 11/15/2018 | ALKS | Buy Now | Alkermes | $27.67 | 30.1% | Paul Matteis41% | → $36 | Initiates | → Market Perform | Get Alert |
| 11/13/2018 | ALKS | Buy Now | Alkermes | $27.67 | 30.1% | Paul Matteis41% | → $36 | Initiates | → Market Perform | Get Alert |
| 11/13/2018 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Paul Matteis41% | → $185 | Initiates | → Outperform | Get Alert |
| 11/13/2018 | NBIX | Buy Now | Neurocrine Biosciences | $105.76 | 4.01% | Paul Matteis41% | → $110 | Initiates | → Market Perform | Get Alert |
| 11/13/2018 | ZGNX | Buy Now | Zogenix | — | — | Paul Matteis41% | → $60 | Initiates | → Outperform | Get Alert |
| 10/05/2018 | ACOR | Buy Now | Acorda Therapeutics | — | — | Paul Matteis41% | $3000 → $2280 | Maintains | Hold | Get Alert |
| 09/25/2018 | IONS | Buy Now | Ionis Pharmaceuticals | $29.57 | 62.33% | Paul Matteis41% | $45 → $48 | Maintains | Hold | Get Alert |
| 09/25/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Paul Matteis41% | $25 → $31 | Maintains | Hold | Get Alert |
| 09/20/2018 | NBIX | Buy Now | Neurocrine Biosciences | $105.76 | 34.27% | Paul Matteis41% | $137 → $142 | Maintains | Buy | Get Alert |
| 09/13/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -51.6% | Paul Matteis41% | $123 → $117 | Maintains | Buy | Get Alert |
| 08/28/2018 | IONS | Buy Now | Ionis Pharmaceuticals | $29.57 | 52.18% | Paul Matteis41% | $47 → $45 | Maintains | Hold | Get Alert |
| 08/28/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Paul Matteis41% | $33 → $25 | Maintains | Hold | Get Alert |
| 08/15/2018 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Paul Matteis41% | → $181 | Initiates | → Buy | Get Alert |
| 08/07/2018 | NBIX | Buy Now | Neurocrine Biosciences | $105.76 | 29.54% | Paul Matteis41% | → $137 | Initiates | → Buy | Get Alert |
| 02/28/2018 | IONS | Buy Now | Ionis Pharmaceuticals | $29.57 | 92.76% | Paul Matteis41% | $55 → $57 | Maintains | Hold | Get Alert |
| 02/27/2018 | OBSV | Buy Now | ObsEva | — | — | Paul Matteis41% | $17 → $18 | Maintains | Outperform | Get Alert |
| 02/23/2018 | ZGNX | Buy Now | Zogenix | — | — | Paul Matteis41% | $50 → $54 | Maintains | Outperform | Get Alert |
| 02/21/2018 | WVE | Buy Now | WAVE Life Sciences | $6.79 | 842.56% | Paul Matteis41% | $53 → $64 | Maintains | Outperform | Get Alert |
| 02/06/2018 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Paul Matteis41% | $153 → $157 | Maintains | Outperform | Get Alert |
| 01/25/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -44.16% | Paul Matteis41% | $132 → $135 | Maintains | Market Perform | Get Alert |
| 11/02/2017 | NBIX | Buy Now | Neurocrine Biosciences | $105.76 | -21.52% | Paul Matteis41% | $72 → $83 | Maintains | Outperform | Get Alert |
| 10/09/2017 | AKAO | Buy Now | Achaogen | — | — | Paul Matteis41% | $28 → $22 | Maintains | Outperform | Get Alert |
| 10/02/2017 | ZGNX | Buy Now | Zogenix | — | — | Paul Matteis41% | $20 → $50 | Maintains | Outperform | Get Alert |
| 10/02/2017 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Paul Matteis41% | $160 → $153 | Maintains | Outperform | Get Alert |
| 09/21/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -53.67% | Paul Matteis41% | $72 → $112 | Maintains | Market Perform | Get Alert |
| 06/13/2017 | ALKS | Buy Now | Alkermes | $27.67 | — | Paul Matteis41% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/21/2017 | OBSV | Buy Now | ObsEva | — | — | Paul Matteis41% | — | Initiates | → Outperform | Get Alert |
| 01/04/2017 | AKAO | Buy Now | Achaogen | — | — | Paul Matteis41% | → $21 | Initiates | → Outperform | Get Alert |
| 12/21/2016 | CDTX | Buy Now | Cidara Therapeutics | $21.48 | -20.86% | Paul Matteis41% | → $340 | Initiates | → Outperform | Get Alert |
| 10/06/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -83.45% | Paul Matteis41% | $107 → $40 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/04/2016 | ALKS | Buy Now | Alkermes | $27.67 | 106% | Paul Matteis41% | → $57 | Assumes | → Outperform | Get Alert |
| 10/04/2016 | ZGNX | Buy Now | Zogenix | — | — | Paul Matteis41% | → $17 | Assumes | → Outperform | Get Alert |
| 10/04/2016 | NBIX | Buy Now | Neurocrine Biosciences | $105.76 | -33.81% | Paul Matteis41% | → $70 | Assumes | → Outperform | Get Alert |
| 10/04/2016 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Paul Matteis41% | — | Assumes | → Outperform | Get Alert |
| 05/03/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -55.74% | Paul Matteis41% | $120 → $107 | Maintains | Outperform | Get Alert |
| 02/16/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -50.36% | Paul Matteis41% | $152 → $120 | Maintains | Outperform | Get Alert |
| 12/01/2015 | VRTX | Buy Now | Vertex Pharmaceuticals | $489.85 | -74.48% | Paul Matteis41% | → $125 | Initiates | → Buy | Get Alert |
| 11/10/2015 | ZGNX | Buy Now | Zogenix | — | — | Paul Matteis41% | $27 → $26 | Maintains | Outperform | Get Alert |
| 11/10/2015 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -37.13% | Paul Matteis41% | $151 → $152 | Maintains | Outperform | Get Alert |
| 11/06/2015 | ALKS | Buy Now | Alkermes | $27.67 | 203.58% | Paul Matteis41% | $81 → $84 | Maintains | Outperform | Get Alert |
| 08/31/2015 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -37.54% | Paul Matteis41% | $145 → $151 | Maintains | Outperform | Get Alert |
| 08/11/2015 | ZGNX | Buy Now | Zogenix | — | — | Paul Matteis41% | $24 → $27 | Maintains | Outperform | Get Alert |
| 07/21/2015 | NBIX | Buy Now | Neurocrine Biosciences | $105.76 | — | Paul Matteis41% | — | Assumes | → Outperform | Get Alert |
| 04/14/2015 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Paul Matteis41% | $102 → $120 | Maintains | Outperform | Get Alert |
| 02/04/2014 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Paul Matteis41% | — | Initiates | → Outperform | Get Alert |
| 09/23/2013 | ALNY | Buy Now | Alnylam Pharmaceuticals | $241.75 | -66.91% | Paul Matteis41% | $57 → $80 | Maintains | Outperform | Get Alert |
| 05/29/2013 | ALKS | Buy Now | Alkermes | $27.67 | — | Paul Matteis41% | — | Initiates | → Outperform | Get Alert |
